Search

Search Constraints

You searched for: Author/Creator Brekke, Jorunn

Search Results

1. "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients ‐ 30 months follow‐up": Reply. (20th July 2022)

2. Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up. (20th February 2022)

3. Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study. Issue 3 (24th June 2020)

4. Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism. Issue 196 (December 2020)